FDA Inspection 916736 — Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated — FEI 1000513211

The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on February 17, 2015 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Sponsor, Contract Research Organization